Evidence map›Paper›PMID 39117661›Full record

ArticleNature communications2024

Multi-omics characterization of the monkeypox virus infection.

Yiqi Huang, Valter Bergant, Vincent Grass, Quirin Emslander, M Sabri Hamad, Philipp Hubel, Julia Mergner, Antonio Piras, Karsten Krey, Alexander Henrici and 12 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yiqi Huang *Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.ORCID 0000-0001-7256-8699
Valter Bergant *Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.ORCID 0000-0003-3458-9506
Vincent Grass *Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.ORCID 0000-0001-7710-4789
Quirin Emslander *Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.
M Sabri HamadInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.ORCID 0000-0002-3684-6388
Philipp HubelInnate Immunity Laboratory, Max-Planck Institute of Biochemistry, Munich, Germany.
Julia MergnerBavarian Center for Biomolecular Mass Spectrometry at University Hospital rechts der Isar (BayBioMS@MRI), Technical University of Munich, Munich, Germany.ORCID 0000-0002-4332-1280
Antonio PirasInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.
Karsten KreyInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.ORCID 0000-0002-1280-4722
Alexander HenriciInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.
Rupert ÖllingerInstitute of Molecular Oncology and Functional Genomics and Department of Medicine II, School of Medicine, Technical University of Munich, Munich, Germany.ORCID 0000-0002-2292-5982
Yonas M TesfamariamInstitute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany.ORCID 0000-0003-0106-7277
Ilaria Dalla RosaCellular signalling and cytoskeletal function laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Till BunseInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.ORCID 0000-0002-2175-7008
Gerd SutterInstitute for Infectious Diseases and Zoonoses, Department of Veterinary Sciences, LMU Munich, Munich, Germany.
Gregor EbertInstitute of Virology, Technical University of Munich, School of Medicine/Helmholtz Munich, Munich, Germany.ORCID 0000-0002-5318-3037
Florian I SchmidtInstitute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany.ORCID 0000-0002-9979-9769
Michael WayCellular signalling and cytoskeletal function laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.ORCID 0000-0001-7207-2722
Roland RadInstitute of Molecular Oncology and Functional Genomics and Department of Medicine II, School of Medicine, Technical University of Munich, Munich, Germany.ORCID 0000-0002-6849-9659
Andrew G BowieSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0001-5316-4373
Ulrike ProtzerGerman Centre for Infection Research (DZIF), Partner site Munich, Munich, Germany.
Andreas PichlmairInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany. andreas.pichlmair@tum.de.ORCID 0000-0002-0166-1367

Funding

Cancer Research UK CC2096Deutsche Forschungsgemeinschaft (German Research Foundation) TRR179-272983813, TRR237-369799452, TRR353-471011418, INST 95/1650-1Helmholtz Association KA1-Co-02Medical Research Council CC2096Wellcome Trust CC2096
6 · The paper itself

Abstract

Multiple omics analyzes of Vaccinia virus (VACV) infection have defined molecular characteristics of poxvirus biology. However, little is known about the monkeypox (mpox) virus (MPXV) in humans, which has a different disease manifestation despite its high sequence similarity to VACV. Here, we perform an in-depth multi-omics analysis of the transcriptome, proteome, and phosphoproteome signatures of MPXV-infected primary human fibroblasts to gain insights into the virus-host interplay. In addition to expected perturbations of immune-related pathways, we uncover regulation of the HIPPO and TGF-β pathways. We identify dynamic phosphorylation of both host and viral proteins, which suggests that MAPKs are key regulators of differential phosphorylation in MPXV-infected cells. Among the viral proteins, we find dynamic phosphorylation of H5 that influenced the binding of H5 to dsDNA. Our extensive dataset highlights signaling events and hotspots perturbed by MPXV, extending the current knowledge on poxviruses. We use integrated pathway analysis and drug-target prediction approaches to identify potential drug targets that affect virus growth. Functionally, we exemplify the utility of this approach by identifying inhibitors of MTOR, CHUK/IKBKB, and splicing factor kinases with potent antiviral efficacy against MPXV and VACV.

Indexed as

FibroblastsMonkeypox virusMpox, MonkeypoxViral ProteinsAntiviral AgentsHost-Pathogen InteractionsHumansMultiomicsPhosphorylationProteomeProteomicsSignal TransductionTranscriptomeAntiviral AgentsProteomeViral Proteins

Identifiers

PMID39117661
PMCPMC11310467

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.